July 30 (Reuters) – Iksuda Therapeutics: * IKSUDA RECEIVES US FDA IND CLEARANCE FOR IKS04 Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Spain extend De la Fuente contract until 2032 after World Cup triumph
VIDEO SHOWS: COMMENTS FROM SPAIN COACH LUIS DE LA FUENTE DURING CONTRACT RENOVATION EVENT, FILE…
S&P 500 COMMUNICATION SERVICES SECTOR INDEX AT HIGHEST SINCE AUG 5, LAST UP 3%
S&P 500 COMMUNICATION SERVICES SECTOR INDEX AT HIGHEST SINCE AUG 5, LAST UP 3% (The…
Paramount settles states' challenge to Warner Bros merger, Bloomberg News reports
Sept 21 (Reuters) - Paramount Skydance has reached a settlement with California and other states…
